rheumatoid arthritis glp 1 Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity? Comparative risk of rheumatoid arthritis
Description
Aliotta A, et al
The study also assessed safety outcomes
Receptor-mediated mitophagy in yeast and mammalian systems
Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et al
By PharmaCompass 2023-06-29 Impressions: 3152 Last month, Novo Nordisk paused all advertising for Wegovy (semaglutide) amid skyrocketing demand and short supply
